We’ve spent the past year on Post-Hoc Live talk­ing about ex­is­ten­tial mo­ments for US biotech — the down­turn, the re­cov­ery, Chi­na, MFN and more. On Wednes­day’s show, we’re joined by one of the lead­ing in­dus­try vet­er­ans sound­ing the alarm.

Je­re­my Levin has seen bio­phar­ma from prac­ti­cal­ly every van­tage point — he’s led deal­mak­ing in big phar­ma, found­ed biotechs and tak­en the big-pic­ture per­spec­tive as chair­man of BIO. Like many ex­pe­ri­enced bio­phar­ma lead­ers, he’s wor­ried about US pol­i­cy and he’s wor­ried about Chi­na.

At 11:30 am ET, I’ll talk with Dr. Levin about what the biggest prob­lems have been, and what so­lu­tions US pol­i­cy­mak­ers should put in place. (He al­so has a new book out where he talks about many of these is­sues.)

You can join us live on YouTube here. Or add us to your Google or Out­look cal­en­dar to get a re­minder be­fore we go live.

See you soon!